Clinical Trial Update: Herzuma-capecitabine/Cisplatin for Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Herzuma (trastuzumab) with capecitabine and cisplatin for HER-2 positive gastric cancer, including metastatic disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Capecitabine (capecitabine)
• HERZUMA (TRASTUZUMAB)

Snippet

Sponsor: Sung Yong Oh | Conditions: HER-2 Positive Gastric Cancer, Metastatic Cancer | Phase 2 | Status: UNKNOWN